Meridian Bioscience Inc (NASDAQ:VIVO)

18.14
Delayed Data
As of 3:59pm ET
 -0.09 / -0.49%
Today’s Change
5.51
Today|||52-Week Range
26.58
+85.67%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 24.00, with a high estimate of 34.00 and a low estimate of 19.00. The median estimate represents a +32.30% increase from the last price of 18.14.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Meridian Bioscience Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.17
Sales
$62.2M
Reporting Date
Nov 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -68.64%
 
 
 
 
 
 
Growthannually 31.99%
 
 
 
 
 
 

Sales

Growthquarterly -26.68%
 
 
 
 
 
 
Growthannually 20.92%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.